120 related articles for article (PubMed ID: 38184300)
21. PEPFAR's biggest success is also its largest liability.
Navario P
Lancet; 2009 Jul; 374(9685):184-5. PubMed ID: 19616705
[No Abstract] [Full Text] [Related]
22. PEPFAR's evolving HIV prevention approaches for key populations--people who inject drugs, men who have sex with men, and sex workers: progress, challenges, and opportunities.
Needle R; Fu J; Beyrer C; Loo V; Abdul-Quader AS; McIntyre JA; Li Z; Mbwambo JK; Muthui M; Pick B
J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3():S145-51. PubMed ID: 22797736
[TBL] [Abstract][Full Text] [Related]
23. PEPFAR's past and future efforts to cut costs, improve efficiency, and increase the impact of global HIV programs.
Holmes CB; Blandford JM; Sangrujee N; Stewart SR; DuBois A; Smith TR; Martin JC; Gavaghan A; Ryan CA; Goosby EP
Health Aff (Millwood); 2012 Jul; 31(7):1553-60. PubMed ID: 22778345
[TBL] [Abstract][Full Text] [Related]
24. How PEPFAR's public-private partnerships achieved ambitious goals, from improving labs to strengthening supply chains.
Sturchio JL; Cohen GM
Health Aff (Millwood); 2012 Jul; 31(7):1450-8. PubMed ID: 22778334
[TBL] [Abstract][Full Text] [Related]
25. Countries where HIV is concentrated among most-at-risk populations get disproportionally lower funding from PEPFAR.
Grosso AL; Tram KH; Ryan O; Baral S
Health Aff (Millwood); 2012 Jul; 31(7):1519-28. PubMed ID: 22778341
[TBL] [Abstract][Full Text] [Related]
26. PEPFAR Investments In Governance And Health Systems Were One-Fifth Of Countries' Budgeted Funds, 2004-14.
Moucheraud C; Sparkes S; Nakamura Y; Gage A; Atun R; Bossert TJ
Health Aff (Millwood); 2016 May; 35(5):847-55. PubMed ID: 27140991
[TBL] [Abstract][Full Text] [Related]
27. PEPFAR's support for orphans and vulnerable children: some beneficial effects, but too little data, and programs spread thin.
Bryant M; Beard J; Sabin L; Brooks MI; Scott N; Larson BA; Biemba G; Miller C; Simon J
Health Aff (Millwood); 2012 Jul; 31(7):1508-18. PubMed ID: 22778340
[TBL] [Abstract][Full Text] [Related]
28. Investing in HIV services while building Kenya's health system: PEPFAR's support to prevent mother-to-child HIV transmission.
Dutta A; Wallace N; Savosnick P; Adungosi J; Kioko UM; Stewart S; Hijazi M; Gichanga B
Health Aff (Millwood); 2012 Jul; 31(7):1498-507. PubMed ID: 22778339
[TBL] [Abstract][Full Text] [Related]
29. Four principles for expanding PEPFAR's role as a vital force in US health diplomacy abroad.
Collins C; Isbell M; Sohn A; Klindera K
Health Aff (Millwood); 2012 Jul; 31(7):1578-84. PubMed ID: 22778348
[TBL] [Abstract][Full Text] [Related]
30. Saving lives for a lifetime: supporting orphans and vulnerable children impacted by HIV/AIDS.
Nyberg BJ; Yates DD; Lovich R; Coulibaly-Traore D; Sherr L; Thurman TR; Sampson A; Howard B
J Acquir Immune Defic Syndr; 2012 Aug; 60 Suppl 3():S127-35. PubMed ID: 22797734
[TBL] [Abstract][Full Text] [Related]
31. Progress in voluntary medical male circumcision for HIV prevention supported by the US President's Emergency Plan for AIDS Relief through 2017: longitudinal and recent cross-sectional programme data.
Davis SM; Hines JZ; Habel M; Grund JM; Ridzon R; Baack B; Davitte J; Thomas A; Kiggundu V; Bock N; Pordell P; Cooney C; Zaidi I; Toledo C
BMJ Open; 2018 Sep; 8(8):e021835. PubMed ID: 30173159
[TBL] [Abstract][Full Text] [Related]
32. Replicating PEPFAR's success: how interventions shown to be effective abroad can be applied to the AIDS epidemic in the US.
Fu J; Gavaghan A; Millett G; Walsh T
Health Aff (Millwood); 2012 Jul; 31(7):1585-92. PubMed ID: 22778349
[TBL] [Abstract][Full Text] [Related]
33. Potential impact of the US President's Emergency Plan for AIDS relief on the tuberculosis/HIV coepidemic in selected Sub-Saharan African countries.
Lima VD; Granich R; Phillips P; Williams B; Montaner JS
J Infect Dis; 2013 Dec; 208(12):2075-84. PubMed ID: 23911712
[TBL] [Abstract][Full Text] [Related]
34. The reach and limits of the US President's Emergency Plan for Aids Relief (PEPFAR) funding of Prevention of Mother-to-Child Transmission (PMTCT) of HIV in Nigeria.
Ezegbe C; Stephenson N
Afr J Reprod Health; 2012 Mar; 16(1):23-34. PubMed ID: 22783665
[TBL] [Abstract][Full Text] [Related]
35. The Medical Education Partnership Initiative: PEPFAR's effort to boost health worker education to strengthen health systems.
Mullan F; Frehywot S; Omaswa F; Sewankambo N; Talib Z; Chen C; Kiarie J; Kiguli-Malwadde E
Health Aff (Millwood); 2012 Jul; 31(7):1561-72. PubMed ID: 22778346
[TBL] [Abstract][Full Text] [Related]
36. HIV Policy Advancements in PEPFAR Partner countries: a review of data from 2010-2016.
Verani AR; Lane J; Lim T; Kaliel D; Katz A; Palen J; Timberlake J
Glob Public Health; 2021 Mar; 16(3):390-400. PubMed ID: 32748699
[TBL] [Abstract][Full Text] [Related]
37. HIV development assistance and adult mortality in Africa.
Bendavid E; Holmes CB; Bhattacharya J; Miller G
JAMA; 2012 May; 307(19):2060-7. PubMed ID: 22665105
[TBL] [Abstract][Full Text] [Related]
38. Analysis of maternal and child health spillover effects in PEPFAR countries.
Gaumer G; Crown WH; Kates J; Luan Y; Hariharan D; Jordan M; Hurley CL; Nandakumar A
BMJ Open; 2023 Dec; 13(12):e070221. PubMed ID: 38135335
[TBL] [Abstract][Full Text] [Related]
39. Low-cost generic drugs under the President's Emergency Plan for AIDS Relief drove down treatment cost; more are needed.
Venkatesh KK; Mayer KH; Carpenter CC
Health Aff (Millwood); 2012 Jul; 31(7):1429-38. PubMed ID: 22778332
[TBL] [Abstract][Full Text] [Related]
40. Building sustainable organizational capacity to deliver HIV programs in resource-constrained settings: stakeholder perspectives.
Sharma A; Chiliade P; Michael Reyes E; Thomas KK; Collens SR; Rafael Morales J
Glob Health Action; 2013 Dec; 6():22571. PubMed ID: 24331715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
